WASATCH ADVISORS LP

Position in VKTX — Viking Therapeutics, Inc.

CIK 814133 SALT LAKE CITY, UT

Position in VKTX

as of Jun 30, 2026 · filed Jul 10, 2026 Compact

Position Value

$12,201,040

+$2,010,879 QoQ

Shares Held

312,767

-0.1% QoQ

Ownership

0.268%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#45

of 432 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WASATCH ADVISORS LP holds $96,311,805 across 9 Biotechnology names. VKTX ranks #4 (12.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TARS	Tarsus Pharmaceuticals, Inc.	368,568	$23,197,669
2	CCCC	C4 Therapeutics, Inc.	3,522,644	$16,450,747
3	PHAT	Phathom Pharmaceuticals, Inc.	1,307,247	$14,183,629
4	VKTX	Viking Therapeutics, Inc. This page	312,767	$12,201,040
5	DYN	Dyne Therapeutics, Inc.	443,668	$9,853,866
6	MGNX	Macrogenics Inc	2,018,881	$9,327,230
7	IMTX	Immatics N.V.	441,510	$4,472,496
8	NKTX	Nkarta, Inc.	1,577,847	$4,465,307

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,201,040	312,767	-0.1%	Shares	Sole	2026-07-10
2026-03-31	$10,190,161	313,158	+89.3%	Shares	Sole	2026-04-21
2025-12-31	$5,818,983	165,406	+28.8%	Shares	Sole	2026-02-12
2025-09-30	$3,376,112	128,467	-51.0%	Shares	Sole	2025-11-14
2025-06-30	$6,944,192	262,045	+1.8%	Shares	Sole	2025-08-14
2025-03-31	$6,217,369	257,448	+42.3%	Shares	Sole	2025-05-15
2024-12-31	$7,280,140	180,918	-20.6%	Shares	Sole	2025-02-13
2024-09-30	$14,416,953	227,720	-10.1%	Shares	Sole	2024-11-14
2024-06-30	$13,420,488	253,169	-0.9%	Shares	Sole	2024-08-14
2024-03-31	$20,953,952	255,536	-80.0%	Shares	Sole	2024-04-18
2023-12-31	$23,726,726	1,274,945	+32.4%	Shares	Sole	2024-02-14
2023-09-30	$10,663,332	963,264	-43.7%	Shares	Sole	2023-11-14
2023-06-30	$27,710,589	1,709,475	+0.2%	Shares	Sole	2023-08-08
2023-03-31	$28,395,642	1,705,444	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.